Zobrazeno 1 - 10
of 78
pro vyhledávání: '"B S, Baker"'
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 32(7)
Relative expression of miR-21-5p in serum was upregulated in response to 30 days of bed rest, and miRNA fold changes were positively associated with serum calcium changes.Circulating miRNAs (c-miRNAs) have potential as biomarkers of cellular activity
Publikováno v:
Journal of sports sciences. 37(19)
Cyclists may be at greater risk of developing asymmetrical force and motion patterns than other ground-based athletes. However, functional asymmetries during cycling tend to be highly variable, making them difficult to assess. Dual-energy x-ray absor
Autor:
James R.C. Parkinson, Sarah Rogers, Damian Smedley, Lionel Fry, Ann Caird, Celine Charon, Stephanie Halford, B. S. Baker, A.V. Powles, Mark I. McCarthy
Evidence, largely from Irish pedigrees, indicates that a susceptibility locus for psoriasis maps to chromosome 4q. The gene encoding interferon regulatory factor-2 ( IRF-2 ) maps to this region, and, as mice lacking IRF-2 exhibit a dermatologic pheno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6c2f7b50d9f20d951609e69d6c52c6
https://doi.org/10.1046/j.0022-202x.2004.22135.x
https://doi.org/10.1046/j.0022-202x.2004.22135.x
Autor:
B S Baker
Publikováno v:
Occupational Medicine. 68:430-430
Autor:
Marco Zucchelli, A.V. Powles, Lena Samuelsson, Ulpu Saarialho-Kere, Juha Kere, Sari Suomela, Kati Kainu, B. S. Baker, Annica Inerot, L. Fry, Katja Kivinen
Publikováno v:
Experimental Dermatology. 18:109-115
A susceptibility locus for psoriasis, PSORS4, has been mapped to chromosome 1q21 in the region of the epidermal differentiation complex. The region has been refined to a 115 kb interval around the loricrin (LOR) gene. However, no evidence of associat
Autor:
B. S. Baker, L. Fry
Publikováno v:
Drug Discovery Today: Therapeutic Strategies. 4:201-207
Biological therapies targeting T cell activation and trafficking, and the cytokine TNF-α have recently been approved for use in psoriasis and/or psoriatic arthritis. Clinical evidence suggests that they are both safe and efficacious for moderate to
Publikováno v:
Clinical and Developmental Immunology, Vol 13, Iss 2-4, Pp 361-367 (2006)
Clinical and Developmental Immunology
Clinical and Developmental Immunology
Psoriasis is most common in the northern European countries, with an incidence of 2.9% in Denmark and 2.8% in the Faroe Isles. The average incidence in European countries is given as 2% and is slightly lower in the USA, being 1.5%. In the Middle East
Autor:
Jane S. A. Voerman, L van der Fits, M-J Melief, L. Fry, B. S. Baker, A.V. Powles, Jon D. Laman
Publikováno v:
The Journal of Pathology. 209:174-181
We have previously demonstrated, in psoriatic skin lesions, the presence of a subset of dermal CD4+ T cells that produce interferon-γ (IFN-γ) in response to a mixture of cell wall proteins extracted from group A streptococci. However, the identity
Publikováno v:
Scandinavian Journal of Immunology. 58:335-341
We have recently described a dermal Th-1 subset in skin lesions of psoriasis which recognizes cell-wall extract isolated from group A streptococci (GAS). As a first step in the identification of the streptococcal proteins involved, dermal T-cell line
Publikováno v:
British Journal of Dermatology. 148:670-679
SummaryBackground Toll-like receptors (TLRs) are part of the innate immune system involved in the response to microbial pathogens. TLR2 recognizes various ligands expressed by Gram-positive bacteria, while TLR3, TLR4 and TLR5 are specific for double-